LTR Pharma Limited (AU:LTP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited is set to capture attention in the financial markets with its new fast-acting nasal spray treatment for erectile dysfunction, targeting sophisticated investors across multiple countries. The company is actively engaging with institutional accredited investors for capital raising opportunities.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.